Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hidradenitis Suppurativa - Overview
Hidradenitis Suppurativa - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Hidradenitis Suppurativa - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hidradenitis Suppurativa - Companies Involved in Therapeutics Development
AbbVie Inc
Aclaris Therapeutics Inc
Alvotech ehf
AstraZeneca Plc
Celgene Corp
ChemoCentryx Inc
CSL Ltd
Foamix Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd
Immunwork Inc
Incyte Corp
InflaRx NV
Innovation Pharmaceuticals Inc
InSight Biopharmaceuticals Ltd
Johnson & Johnson
Novartis AG
UCB SA
XBiotech Inc
Hidradenitis Suppurativa - Drug Profiles
ABBV-3373 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
adalimumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
adalimumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
adalimumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
adalimumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
adalimumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
apremilast - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ATI-450 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
avacopan - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bermekimab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bimekizumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
brilacidin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
brodalumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CJM-112 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-324 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
doxycycline hyclate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GBR-830 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
guselkumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IFX-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
INCB-54707 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
iscalimab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LYS-006 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
risankizumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
secukinumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TE-2232 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hidradenitis Suppurativa - Dormant Projects
Hidradenitis Suppurativa - Discontinued Products
Hidradenitis Suppurativa - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Hidradenitis Suppurativa, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Hidradenitis Suppurativa, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Hidradenitis Suppurativa - Pipeline by AbbVie Inc, H2 2019
Hidradenitis Suppurativa - Pipeline by Aclaris Therapeutics Inc, H2 2019
Hidradenitis Suppurativa - Pipeline by Alvotech ehf, H2 2019
Hidradenitis Suppurativa - Pipeline by AstraZeneca Plc, H2 2019
Hidradenitis Suppurativa - Pipeline by Celgene Corp, H2 2019
Hidradenitis Suppurativa - Pipeline by ChemoCentryx Inc, H2 2019
Hidradenitis Suppurativa - Pipeline by CSL Ltd, H2 2019
Hidradenitis Suppurativa - Pipeline by Foamix Pharmaceuticals Ltd, H2 2019
Hidradenitis Suppurativa - Pipeline by Glenmark Pharmaceuticals Ltd, H2 2019
Hidradenitis Suppurativa - Pipeline by Immunwork Inc, H2 2019
Hidradenitis Suppurativa - Pipeline by Incyte Corp, H2 2019
Hidradenitis Suppurativa - Pipeline by InflaRx NV, H2 2019
Hidradenitis Suppurativa - Pipeline by Innovation Pharmaceuticals Inc, H2 2019
Hidradenitis Suppurativa - Pipeline by InSight Biopharmaceuticals Ltd, H2 2019
Hidradenitis Suppurativa - Pipeline by Johnson & Johnson, H2 2019
Hidradenitis Suppurativa - Pipeline by Novartis AG, H2 2019
Hidradenitis Suppurativa - Pipeline by UCB SA, H2 2019
Hidradenitis Suppurativa - Pipeline by XBiotech Inc, H2 2019
Hidradenitis Suppurativa - Dormant Projects, H2 2019
Hidradenitis Suppurativa - Discontinued Products, H2 2019